Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
International Clinical Psychopharmacology
|
October 12, 2013
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison
Dong-Jing Fu, Cynthia A Bossie, Jennifer K Sliwa, et al.
Schizophrenia Research
|
March 5, 2022
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder
Larry Alphs, Brianne Brown, Ibrahim Turkoz, et al.
Clinical Schizophrenia & Related Psychoses
|
March 1, 2013
Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens
Dong-Jing Fu, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Journal of Affective Disorders
|
April 10, 2024
Self-administered generational surveys combine with genetic analysis to reveal foundations of depression in Japanese adults
Ryo Takano, Yushin Tominaga, Dong-Jing Fu, et al.
BMC Psychiatry
|
May 17, 2011
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
Cynthia A Bossie, Jennifer K Sliwa, Yi-Wen Ma, et al.
Expert Opinion on Pharmacotherapy
|
April 24, 2014
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
Larry Alphs, Cynthia A Bossie, Dong-Jing Fu, et al.
Schizophrenia Research
|
August 8, 2022
Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Larry Alphs, Pamela Baker, Brianne Brown, et al.
Schizophrenia Research
|
April 30, 2017
Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in subjects with schizoaffective disorder
Dong-Jing Fu, Ibrahim Turkoz, David Walling, et al.
Psychiatry Research
|
October 17, 2020
Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide Assessment
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Psychological Medicine
|
August 23, 2023
Comments to Drs Taillefer de Laportalière, Jullien, Yrondi, Cestac, and Montastruc
Dong-Jing Fu, Cynthia A Bossie, Rosanne Lane, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
International Clinical Psychopharmacology
|
October 12, 2013
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison
Dong-Jing Fu, Cynthia A Bossie, Jennifer K Sliwa, et al.
Schizophrenia Research
|
March 5, 2022
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder
Larry Alphs, Brianne Brown, Ibrahim Turkoz, et al.
Clinical Schizophrenia & Related Psychoses
|
March 1, 2013
Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens
Dong-Jing Fu, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Journal of Affective Disorders
|
April 10, 2024
Self-administered generational surveys combine with genetic analysis to reveal foundations of depression in Japanese adults
Ryo Takano, Yushin Tominaga, Dong-Jing Fu, et al.
BMC Psychiatry
|
May 17, 2011
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
Cynthia A Bossie, Jennifer K Sliwa, Yi-Wen Ma, et al.
Expert Opinion on Pharmacotherapy
|
April 24, 2014
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
Larry Alphs, Cynthia A Bossie, Dong-Jing Fu, et al.
Schizophrenia Research
|
August 8, 2022
Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Larry Alphs, Pamela Baker, Brianne Brown, et al.
Schizophrenia Research
|
April 30, 2017
Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in subjects with schizoaffective disorder
Dong-Jing Fu, Ibrahim Turkoz, David Walling, et al.
Psychiatry Research
|
October 17, 2020
Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide Assessment
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Psychological Medicine
|
August 23, 2023
Comments to Drs Taillefer de Laportalière, Jullien, Yrondi, Cestac, and Montastruc
Dong-Jing Fu, Cynthia A Bossie, Rosanne Lane, et al.
Page
of 8